首页 | 本学科首页   官方微博 | 高级检索  
     

喹硫平与利培酮治疗精神分裂症3个月随访对照研究
引用本文:宋乐鸥. 喹硫平与利培酮治疗精神分裂症3个月随访对照研究[J]. 中国现代医生, 2011, 49(16): 10-11,61
作者姓名:宋乐鸥
作者单位:乐清市人民医院心理科,浙江乐清,325600
摘    要:目的比较喹硫平与利培酮治疗精神分裂症患者的疗效和不良反应发生情况。方法收集单一药物喹硫平(96例)或利培酮(126例)治疗的精神分裂症患者,分别在治疗前和治疗2,4、8、12周,评估阳性与阴性症状量表(PANSS)、卡尔加里精神分裂症抑郁量表(CDSS),并记录不良反应的发生情况,比较两种药物在不同治疗时期的疗效和不良反应的差异。结果喹硫平与利培酮治疗精神分裂症总有效率无显著差异,但临床痊愈率喹硫平组略高于利培酮组(16.7%vs8.7%,P=0.045)。PANSS量表五因子分模型分析,喹硫平治疗组阴性因子分和抑郁因子分以及CDSS量表分在治疗第4、8、12周低于利培酮治疗组(P〈0.05)。喹硫平组锥体外系(EPS)相关不良事件如静坐不能、震颤和总EPS发生率较利培酮组更低(P〈0.05)。结论喹硫平与利培酮治疗精神分裂症3个月疗效与不良反应有所不同。

关 键 词:精神分裂症  喹硫平  利培酮  疗效  不良反应

Control Study between Quetiapine and Risperidone in the Treatment of Schizophrenia at Three Monnths
SONG Leou. Control Study between Quetiapine and Risperidone in the Treatment of Schizophrenia at Three Monnths[J]. , 2011, 49(16): 10-11,61
Authors:SONG Leou
Affiliation:SONG Leou Department of Psychological,Leqing City People's Hospital in Zhejiang Province,Leqing 325600,China
Abstract:Objective To compare the therapeutic effects and side effects between quetiapine and risperidone in the treating of schizophrenia.Methods The positive and negative symptom scale(PANSS) and Calgary depression scale were used for schizophrenia(CDSS),the therapeutic effects and side effects were evaluated in 96 cases schizophrenic patients treated with quetiapine and 126 cases patients with risperidone,before therapy and the 2nd,4th,8th,12th weeks after treatment,respectively.Results The total response rates s...
Keywords:Schizophrenia  Quetiapine  Risperidone  Therapeutic effect  Side effect  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号